Rivermark Medical Kicks Off RAPID III Study for Innovative BPH Treatment Rivermark Medical has successfully enrolled its first patient in the RAPID III clinical study, assessing the innovative FloStent™ system for BPH treatment.

Rivermark Medical Kicks Off RAPID III Study for Innovative BPH Treatment #United_States #Las_Vegas,_Nevada #BPH_Treatment #Rivermark_Medical #FloStent